Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?

PloS one - 1 Jan 2014

Moll Guido, Hult Annika, von Bahr Lena, Alm Jessica J, Heldring Nina, Hamad Osama A, Stenbeck-Funke Lillemor, Larsson Stella, Teramura Yuji, Roelofs Helene, Nilsson Bo, Fibbe Willem E, Olsson Martin L, Le Blanc Katarina

Abstract excerpt

Investigation into predictors for treatment outcome is essential to improve the clinical efficacy of therapeutic multipotent mesenchymal stromal cells (MSCs). We therefore studied the possible harmful impact of immunogenic ABO blood groups antigens - genetically governed antigenic determinants -...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ABO Blood-Group System
Share to Adsorption
Share to Antibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Methylation

Share to Mesenchymal Stem Cell Transplantation

Share to Mesenchymal Stem Cells

Share to Treatment Outcome

Share to Up-Regulation

Source

Open in PubMed Open full text

Identifiers

PMID: 24454787
DOI: 10.1371/journal.pone.0085040
PMCID: PMC3890285

Genes

ABO
MSC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24454787-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?PMID 24454787Read ↗

PLTs of blood group A1 donors express increased surface A antigen owing to apheresis and prolonged storage.Semantic proximity Read ↗

Regulation of ABO blood group antigen expression by miR-331-3p and miR-1908-5p during hematopoietic stem cell differentiation.Semantic proximity Read ↗

Blood group ABO antigen expression in human embryonic stem cells and in differentiated hepatocyte- and cardiomyocyte-like cells.Semantic proximity Read ↗

ABO (histo) blood group phenotype development and human reproduction as they relate to ancestral IgM formation: A hypothesis.Semantic proximity Read ↗

"Natural" antibodies and histo-blood groups in biological development with respect to histo-blood group A. A perspective review.Semantic proximity Read ↗

Impact of recipient ABH secretor status on outcome in minor ABO-incompatible hematopoietic stem cell transplantation.Semantic proximity Read ↗

Antigens on red cells.Semantic proximity Read ↗

Leukocyte phenotypic changes in an in vitro model of ABO hemolytic transfusion reaction.Semantic proximity Read ↗

Effects of Neutralization by Soluble ABH Antigens Produced by Transplanted Kidneys From ABO-Incompatible Secretor Donors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.